A Preview Of Chemomab Therapeutics's Earnings


Chemomab Therapeutics CMMB is set to give its latest quarterly earnings report on Friday, 2023-03-31. Here's what investors need to know before the announcement.

Analysts estimate that Chemomab Therapeutics will report an earnings per share (EPS) of $-0.03.

Chemomab Therapeutics bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Historical Earnings Performance

Last quarter the company missed EPS by $0.37, which was followed by a 0.0% drop in the share price the next day.

Here's a look at Chemomab Therapeutics's past performance and the resulting price change:

Quarter Q3 2022 Q2 2022 Q1 2022 Q4 2021
EPS Estimate -0.33 -0.25 -0.240 -0.10
EPS Actual -0.70 -0.54 -0.022 -0.44
Price Change % 0.0% 7.24% 6.2% 7.92%

Stock Performance

Shares of Chemomab Therapeutics were trading at $1.61 as of March 29. Over the last 52-week period, shares are down 67.08%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.

To track all earnings releases for Chemomab Therapeutics visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-EP
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!